Self-reported tobacco smoke exposure and plasma cotinine levels during pregnancy - A validation study in Northern Japan

Science of the Total Environment

Volumn 412-413, Issue , 2011, Pages 114-118

  Sasaki, Seiko ^a   Braimoh, Titilola S ^a   Yila, Thamar A ^b   Yoshioka, Eiji ^a   Kishi, Reiko ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Enzyme linked immunosorbent assay (ELISA); Plasma cotinine; Pregnancy; Secondhand smoke; Smoking

Indexed keywords

BIOCHEMICAL ANALYSIS; BLOOD SAMPLES; COHORT DESIGN; COTININE; CUT-OFF VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; PREGNANCY; PREGNANT WOMAN; PREVALENCE RATES; PUBLIC HEALTH; QUESTIONNAIRE INFORMATION; RECEIVER OPERATING CHARACTERISTIC CURVES; SECONDHAND SMOKES; SMOKING; TOBACCO SMOKE; VALIDATION STUDY;

ENZYMES; OBSTETRICS; PLASMAS; TOBACCO;

SMOKE;

BIOLOGICAL MARKER; COTININE;

BIOMARKER; MATERNAL EFFECT; PLASMA; PREGNANCY; PUBLIC HEALTH; QUESTIONNAIRE SURVEY; SMOKE; SMOKING; TOBACCO;

ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JAPAN; JAPANESE; MATERNAL SMOKING; PASSIVE SMOKING; PREDICTIVE VALUE; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SELF REPORT; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

COHORT STUDIES; COTININE; ENVIRONMENTAL MONITORING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; JAPAN; MATERNAL EXPOSURE; PREGNANCY; PROSPECTIVE STUDIES; SELF REPORT; SMOKING; TOBACCO SMOKE POLLUTION;

JAPAN;

NICOTIANA TABACUM;

EID: 84855832825     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2011.10.019     Document Type: Article

References (42)

1. Akobeng A.K. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 2006, 96:487-491.
2. Al-Delaimy W.K., Crane J., Woodward A. Questionnaire and hair measurement of exposure to tobacco smoke. J Exp Anal Environ Epidemiol 2000, 10(4):378-384.
3. Bavazzano P., Perico A., Boddi V., Lorini C., Cavaciocchi D., Lanciotti E. Most sensitive urinary cotinine cut-off level for environmental tobacco smoke exposure assessment: a pilot study. Ann Ig 2007, 9:225-233.
4. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996, 18(2):188-204.
5. Benowitz N.L., Bernert J.T., Caraballo R.S., Holiday D.B., Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the united states between 1999 and 2004. Am J Epidemiol 2009, 169(2):236-248.
6. Bernert J.T., Mcguffey J.E., Morrison M.A., Pirkle J.L. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography - tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol 2000, 24(5):333-339.
7. Castro A., Monji N. Dietary nicotine and its significance in studies on tobacco smoking. Biochem Arch 1986, 2:91-97.
8. Chien P.F.W., Khan K.S. Evaluation of clinical test. II: assessment of validity. Brit J Obstet Gynaecol 2001, 108:568-572.
9. Chiu H., Wu H.I., Kuo H. The relationship between self-reported tobacco exposure and cotinines in urine and blood for pregnant women. Sci Total Environ 2008, 406:331-336.
10. Davis R.A., Stiles M.F., Debethizy J.D., Reynolds J.H. Dietary nicotine: a source of urinary cotinine. Food Chem Toxicol 1991, 29:821-827.
11. DeLorenze G.N., Kharrazi M., Kaufman F.L., Eskenazi B., Bernert J.T. Exposure to environmental tobacco smoke in pregnant women: the association between self-report and serum cotinine. Environ Res 2002, 90:21-32.
12. Dempsey D., Jacob P., Benowitz N.L. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002, 301(2):594-598.
13. Domino E.F., Hombach E., Demana T. The nicotine content of common vegetables (letter). N Engl J Med 1993, 329:437.
14. Etter J.F., Due T.V., Perneger T.V. Saliva cotinine levels in smokers and non smokers. Am J Epidemiol 2000, 151(3):251-258.
15. Fantuzzi G., Aggazzotti G., Righi E., Facchinetti F., Bertucci E., Kanitz S., et al. Preterm delivery and exposure to active and passive smoking during pregnancy: a case-control study from Italy. Paediatr Perinat Epidemiol 2007, 21:194-200.
16. George L., Granath F., Johansson A.L.V., Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand 2006, 85:1331-1337.
17. Hanke W., Sobala W., Kalinka J. Environmental tobacco smoke exposure among pregnant women: impact on fetal biometry at 20-24 weeks of gestation and newborn child's birth weight. Int Arch Occup Environ Health 2004, 77(1):47-52.
18. Idle J.R. Titrating exposure to tobacco smoke using cotinine - a minefield of misunderstandings. J Clin Epidemiol 1990, 43:313-317.
19. Jaddoe V.W.V., Troe E.J.W.M., Hofman A., Mackenbach J.P., Moll H.A., Steegers E.A.P., et al. Active and passive maternal smoking during pregnancy and the risks of low birth weight and preterm birth: the generation R study. Paed Perinat Epidemiol 2008, 22:162-171.
20. Kaufman F.L., Kharrazi M., DeLorenze G.N., Eskenazi B., Bernert J.T. Estimation of environmental tobacco smoke exposure during pregnancy using a single question on household smokers versus serum cotinine. J Expo Anal Environ Epidemiol 2002, 12:286-295.
21. Kelly J., Matthews K.A., O'Connor M. Smoking in pregnancy: effects on mother and fetus. BJOG: An Int J Obst Gynaecol 2005, 91(2):111-117.
22. Lieberman E., Gremy I., Lang J.M., Cohen A.P. Low birthweight at term and the timing of fetal exposure to maternal smoking. Am J Public Health 1994, 84:1127-1131.
23. Lin W.Y., Lee L.T., Chen C.Y., Lo H., Hsia H.H., Liu I.L., et al. Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes 2002, 26:1232-1238.
24. Lindqvist R., Lendahls L., Tollbom O., Åberg H., Håkansson A. Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women. Acta Obstet Gynecol Scand 2002, 81:240-244.
25. Loebstein R., Lalkin A., Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997, 33:328-343.
26. Loke A.Y., Lam T.H., Pan S.C., Li S.Y., Gao X.J., Song Y.Y. Exposure to and actions against passive smoking in non-smoking pregnant women in Guangzhou China. Acta Obstet Gynecol Scand 2000, 79:947-952.
27. Man C.N., Fathelrahman A.I., Harn G.L., Lajis R., Samin A.S.M., Omar M., et al. Correlation between urinary nicotine, cotinine and self-reported smoking status among educated young adults. Environ Toxicol Pharma 2009, 28:92-96.
28. Matsumoto A., Ino T., Ohta M., Otani T., Hanada S., Sakuraoka A., et al. Enzyme-linked immunosorbent assay of nicotine metabolites. Environ Health Prev Med 2010, 15:211-216. 10.1007/S12199-009-0129-2.
29. McDonald S.D., Perkins S.L., Walker M.C. Correlation between self-reported smoking status and serum cotinine during pregnancy. Addict Behav 2005, 30(4):853-857.
30. Ohmi H., Hirooka K., Mochizuki Y. Fetal growth and the timing of exposure to maternal smoking. Paed Int 2002, 44:55-59.
31. Rebagliato M., Bolúmar F., Florey C.V., Jarvis M.J., Pérez-Hoyos S., Hernández-Aguado I., et al. Variations in cotinine levels in smokers during and after pregnancy. Am J Obstet Gynecol 1998, 178(3):568-571.
32. Sasaki S., Sata F., Katoh S., Saijo Y., Nakajima S., Washino N., et al. Adverse birth outcomes associated with maternal smoking and polymorphisms in the N-Nitrosamine-metabolizing enzyme genes NQO1 and CYP2E1. Am J Epidemil 2008, 167(6):719-726.
33. Sato H., Araki S., Yokoyama K. Policy functions of smoking control in Japan. Environ Health Prev Med 2000, 4:156-164.
34. Tsutsumi A., Kagawa J., Yamano Y. Relation between cotinine in the urine and indices based on self-declared smoking habits. Environ Health Prev Med 2002, 6:240-247.
35. Tunstall-Pedoe H., Woodward M., Brown C.A. Tea drinking, passive smoking, smoking deception, and serum cotinine in the Scottish Heart Health Study. J Clin Epidemiol 1991, 44:1411-1414.
36. Twardella D., Kupper-Nybelen J., Rothenbacher D., Hahmann H., Wusten B., Brenner H. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur Heart J 2004, 25(23):2101-2108.
37. Vartiainen E., Seppala T., Lillsunde P., Puska P. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Comm Health 2002, 56(3):167-170.
38. Webb D.A., Boyd N.R., Messina D., Windsor R.A. The discrepancy between self-reported smoking status and urine cotinine levels among women enrolled in prenatal care at four publicly funded clinical sites. J Public Health Manag Pract 2003, 9(4):322-325.
39. Weinstein S., Obuchowski N.A., Lieber M.L. Clinical evaluation of diagnostic tests. Am J Roentgenol 2005, 184:14-19.
40. Windham G.C., Hopkins B., Fenster L., Swan S.H. Prenatal active and passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology 2000, 11(4):427-433.
41. Wu T., Hu Y., Chen C., Yang F., Li Z., Fang Z., et al. Passive smoking, metabolic gene polymorphisms and infant birth weight in a prospective cohort study of Chinese women. Am J Epidemiol 2007, 166(3):313-322.
42. Yamamoto Y., Nishida N., Tanaka M., Hayashi N., Matsuse R., Nakayama K., et al. Association between passive and active smoking evaluated by salivary cotinine and periodontitis. J Clin Periodontol 2005, 32:1041-1046.